Skip to main content
Shanghai No.1 Pharmacy Co.,Ltd. logo

Shanghai No.1 Pharmacy Co.,Ltd. — Investor Relations & Filings

Ticker · 600833 ISIN · CNE000000412 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,257 across all filing types
Latest filing 2026-02-11 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600833

About Shanghai No.1 Pharmacy Co.,Ltd.

https://shdyyy.com.cn/

Shanghai No.1 Pharmacy Co.,Ltd. is a prominent retail and wholesale pharmaceutical enterprise. The company specializes in the distribution of a wide range of healthcare products, including prescription and over-the-counter medicines, traditional Chinese medicine, medical devices, and health supplements. It operates an extensive network of retail pharmacies, providing professional pharmaceutical services and health consultations. As a key subsidiary of the Bailian Group, the company leverages a robust supply chain and a long-standing brand reputation to serve the healthcare needs of its target market. Its operations encompass both physical storefronts and integrated digital platforms, focusing on quality assurance and professional healthcare delivery.

Recent filings

Filing Released Lang Actions
上海第一医药股份有限公司关于2026年度日常经营性关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the expected daily related-party transactions for the fiscal year 2026 by Shanghai First Pharmaceutical Co., Ltd. It includes details about the nature of the transactions, amounts, related parties, board approvals, and compliance with stock exchange rules. The document is a regulatory announcement about anticipated related-party transactions, not a financial report or audit. It is relatively short (4306 characters) and serves as a formal disclosure to shareholders and the market about related-party dealings, consistent with regulatory filing requirements. Therefore, it fits best under Regulatory Filings (RNS).
2026-02-11 Chinese
上海第一医药股份有限公司第十一届董事会第八次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 11th Board of Directors' 8th (extraordinary) meeting of Shanghai First Medical Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and references related audit and independent director opinions. There is no financial data or comprehensive report content, but rather a governance-related announcement about organizational structure changes and related party transactions. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related governance decisions. The document length is short and focused on board resolutions, not a full report or financial statement.
2026-02-11 Chinese
上海第一医药股份有限公司关于使用闲置自有资金进行委托理财的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Shanghai First Pharmaceutical Co., Ltd. regarding the use of idle self-owned funds for entrusted financial management. It details the investment amount, type, source of funds, approval procedures, risk analysis, and impact on the company. The document is a formal announcement of a financing or capital management activity, specifically about investing idle funds in low-risk financial products. It is not a full financial report, earnings release, or management discussion. It is also not a regulatory filing or certification. The content fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities and capital usage. The document length is under 5,000 characters and contains substantive information about the financing decision, not just a report publication announcement or a brief notice. Therefore, the classification is CAP with high confidence.
2026-01-16 Chinese
上海第一医药股份有限公司第十一届董事会第七次（临时）会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of resolutions passed at a specific board meeting of Shanghai First Medical Co., Ltd. It details the date and method of the meeting, the agenda items discussed, and the voting results. The content focuses on board decisions regarding the use of idle funds for entrusted wealth management and application for a comprehensive credit line from banks. There is no financial data, earnings information, or detailed report content. The document is clearly a Board/Management Information announcement about board meeting resolutions and decisions, not a full report or financial statement. Therefore, the appropriate classification is MANG (Board/Management Information). The document length is short and it is not an announcement of a report publication, so RPA is not suitable.
2026-01-16 Chinese
上海第一医药股份有限公司2025年年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2025 annual performance forecast (业绩预告) issued by Shanghai First Medical Co., Ltd. It provides estimated net profit figures for the full fiscal year 2025, comparing them to the prior year, and explicitly states that the forecast is unaudited and preliminary. The document is short (1237 characters) and serves as an earnings guidance or profit warning rather than a full financial report. It does not contain actual audited financial statements or detailed financial analysis. This type of document is typically classified as an Earnings Release (ER) because it announces key financial results or expectations for a period, often before the full report is available. It is not an Annual Report (10-K) or Interim Report (IR) because it lacks comprehensive financial data and is a forecast rather than a full report. It is not a Report Publication Announcement (RPA) because it contains substantive financial forecast data, not just a notice of report availability. Therefore, the best classification is Earnings Release (ER). FY 2025
2026-01-16 Chinese
上海第一医药股份有限公司关于2025年第三季度业绩说明会召开情况的公告
Call Transcript Classification · 90% confidence The document is an announcement about the holding of the 2025 third quarter earnings explanation meeting (业绩说明会) by Shanghai First Medical Co., Ltd. It describes the meeting date, participants, and a Q&A session with investors regarding the company's products and brands. The document does not contain actual financial statements or detailed financial analysis but rather a summary of the event and investor interaction. The length is short (1346 characters), and it serves as a notice of the meeting and its content rather than the full report or transcript. This fits the category of an Investor Presentation (IP) or possibly a Call Transcript (CT). However, since it is a summary of an earnings explanation meeting and includes Q&A, it aligns best with a Call Transcript (CT) classification, which covers full text transcripts of company conference calls or earnings calls with Q&A. Therefore, the appropriate classification is CT with high confidence.
2025-12-12 Chinese

Browse filings by year

30 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.